$AUNA

Zamora Leon Jesus purchased $27K of AUNA

Zamora Leon Jesus (President) purchased 6,420 shares of AUNA S.A. (AUNA) at $4.15 on 2026-05-29.

Original reporting
SEC EDGAR · Zamora Leon Jesus
Published Jun 2, 2026, 12:48 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AUNA
Neutral
medium confidence
Mentioned
$AUNA
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AUNANeutralLow
01

Why it matters

The transaction is small relative to AUNA's market cap, so price reaction is expected to be muted.

02

Market read

Primary relevance is to AUNA shareholders; broader market impact negligible.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 4/10Novelty 4/10Timing: post-filing today

Background

SEC Form 4 filing reports insider transactions; this is the first public disclosure of the purchase.

Company-level read

Ticker impact

$AUNANeutralMedium confidence
Context

President Zamora Leon Jesus bought 6,420 shares of AUNA at $4.15 each, total $26,643.

Expected impact

modest buying pressure, likely neutral to slight positive

Evidence & confidence

Purchase amount is under $30K and represents a tiny fraction of float; market impact limited.

Market effects

Minimal effect on healthcare sector; insider activity not material.

No discernible impact on broader Latin American markets.

Limited to AUNA shareholders.

Counterpoint

The purchase could be a routine compensation exercise, not a confidence signal.

Key entities

  • Zamora Leon Jesus

    President of AUNA who executed the purchase.

  • AUNA S.A.

    Peruvian healthcare provider listed on NYSE.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AUNAMed

Auna (AUNA) Q2 2026 Earnings Call Transcript

Auna (AUNA) reported Q2 2026 results with 9% revenue growth driven by volume and higher complexity services. Adjusted EBITDA declined 9% due to margin pressures in Mexico and Colombia, and billing penalties in Peru. Mexico saw 7% surgery and 20% oncology volume growth, while Peru achieved 8% revenue growth. Colombia's adjusted EBITDA increased 18% sequentially. Leverage decreased to 3.6x, and cash increased 43% year-over-year.

$AUNAMed

Auna Q2 Earnings Call Highlights

Auna reported Q2 revenue growth in Mexico (4% YoY), Peru (8%), and Colombia (13%), but adjusted EBITDA varied. Mexico's EBITDA declined 16% YoY due to investments, while Peru's was flat due to billing penalties. Colombia's EBITDA fell 12% YoY but rose 18% sequentially. The company reaffirmed its full-year guidance, expecting 12% FX-neutral revenue growth and adjusted EBITDA growth toward the low end of its 10-14% target range, excluding Peru's billing penalties. Cash flow and leverage improved,

$AUNAMed

Auna S.A. Q2 2026 Earnings Call Summary

Auna S.A. reported Q2 2026 revenue growth of 9%, driven by high-complexity services, with adjusted EBITDA declining 9% due to investment costs. Management reaffirmed full-year revenue guidance of 12% growth and expects EBITDA growth at the low end of 10-14%. Free cash flow increased 181% due to working capital management. The company faces short-term penalties in Peru but anticipates improvements in profitability and cash flow.

$AUNAMedAI 9/10

Auna S.A.: Auna Announces 2Q26 Financial Results

Auna S.A. (NYSE: AUNA) reported 2Q26 results with revenue up 9% FX-neutral to S/1,238 million, but Adjusted EBITDA down 9% FX-neutral to S/227 million. Operating cash flow and free cash flow rose 45% and 181% YoY, respectively. The company attributed EBITDA declines to service mix and cost pressures across its Latin American markets. Auna reaffirmed its full-year revenue guidance of 12% growth and expects Adjusted EBITDA growth at the low end of its 10-14% range.

$AUNAMed

AUNA S.A. (AUNA): Financial results for Q2 2026

AUNA S.A. (AUNA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Auna Announces 2Q26 Financial Results A consecutive quarter of strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by service mix across the segments Luxembourg, August 18, 2026 – Auna (NYSE: AUNA) (“Auna” or the “Company”) , a lea